Nicotine in a small-to-moderate dose does not cause a significant increase in plasma catecholamine levels in newborn piglets

Neonatology

Volumn 94, Issue 4, 2008, Pages 279-283

  Andresen, Jannicke Hanne ^a   Godang, Kristin ^c   Munkeby, Berit H ^b   Stray Pedersen, Babill ^b   Saugstad, Ola Didrik ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adrenaline; Catecholamines; Nicotine; Noradrenaline

Indexed keywords

ADRENALIN; NICOTINE TARTRATE; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MECHANISM; EXPERIMENTAL PIG; FEMALE; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NEUROPROTECTION; NEWBORN; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; HEART RATE; HEMOGLOBINS; NICOTINE; NICOTINIC AGONISTS; NOREPINEPHRINE; OXIMETRY; RANDOM ALLOCATION; SWINE; SYMPATHETIC NERVOUS SYSTEM;

ANIMALIA;

EID: 51249108387     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000151647     Document Type: Article

References (28)

1. Neff RA, Simmens SJ, Evans C, Mendelowitz D: Prenatal nicotine exposure alters central cardiorespiratory responses to hypoxia in rats: implications for sudden infant death syndrome. J Neurosci 2004;24:9261-9268.
2. Fewell JE, Smith FG, Ng VK: Threshold levels of maternal nicotine impairing protective responses of newborn rats to intermittent hypoxia. J Appl Physiol 2001;90:1968-1976.
3. Navarro HA, Seidler FJ, Schwartz RD, Baker FE, Dobbins SS, Slotkin TA: Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res Bull 1989;23:187-192.
4. Slotkin TA, McCook EC, Seidler FJ: Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res 1997;750:180-188.
5. Ernst M, Moolchan ET, Robinson ML: Behavioral and neural consequences of prenatal exposure to nicotine. J Am Acad Child Adolesc Psychiatry 2001;40:630-641.
6. Benowitz N: Nicotine Safety and Toxicity. New York, Oxford University Press, 1998.
7. Cormier A, Morin C, Zini R, Tillement J-P, Lagrue G: Nicotine protects rat brain mitochondria against experimental injuries. Neuropharmacology 2003;44:642-652.
8. Cormier A, Morin C, Zini R, Tillement JP, Lagrue G: In vitro effects of nicotine on mitochondrial respiration and superoxide anion generation. Brain Res 2001;900:72-79.
9. Ravikumar R, Flora G, Geddes JW, Hennig B, Toborek M: Nicotine attenuates oxidative stress, activation of redox-regulated transcription factors and induction of proinflammatory genes in compressive spinal cord trauma. Mol Brain Res 2004;124:188-198.
10. Ravikumar R, Fugaccia I, Scheff SW, Geddes JW, Srinivasan C, Toborek M: Nicotine attenuates morphological deficits in a contusion model of spinal cord injury. J Neurotrauma 2005;22:240-251.
11. Laudenbach V, Medja F, Zoli M, Rossi FM, Evrard P, Changeux JP, Gressens P: Selective activation of central subtypes of the nicotinic acetylcholine receptor has opposite effects on neonatal excitotoxic brain injuries. FASEB J 2002;16:423-425.
12. Guan ZZ, Yu WF, Nordberg A: Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem Int 2003;43:243-249.
13. Wittebole X, Hahm S, Coyle SM, Kumar A, Calvano SE, Lowry SF: Nicotine exposure alters in vivo human responses to endotoxin. Clin Exp Immunol 2007;147:28-34.
14. Morens DM, Grandinetti A, Reed D, White LR, Ross GW: Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue? Neurology 1995;45:1041-1051.
15. van Duijn CM, Hofman A: Relation between nicotine intake and Alzheimer's disease. BMJ 1991;302:1491-1494.
16. Krause W, Michael N, Lubke C, Livett BG, Oehme P: Catecholamine release from fractionated chromaffin cells. Eur J Pharmacol 1996;302:223-228.
17. Diana JN, Qian SF, Heesch CM, Barron KW, Chien CY: Nicotine-induced skeletal muscle vasodilation is mediated by release of epinephrine from nerve terminals. Am J Physiol Heart Circ Physiol 1990;259:H1718-H1729.
18. Crystal GJ, Downey HF, Bashour FA: Myocardial oxygen consumption and blood flow during nicotine infusion: effect of combined alpha- and beta-adrenergic blockade. J Cardiovasc Pharmacol 1981;3:317-327.
19. Andresen JH, Solberg R, Loberg EM, Munkeby BH, Stray-Pedersen B, Saugstad OD: Resuscitation with 21 or 100% oxygen in hypoxic nicotine-pretreated newborn piglets: possible neuroprotective effects of nicotine. Neonatology 2007;93:36-44.
20. Symons JD, Stebbins CL: Hemodynamic and regional blood flow responses to nicotine at rest and during exercise. Med Sci Sports Exerc 1996;28:457-467.
21. Benowitz NL: Drug therapy: pharmacologic aspects of cigarette smoking and nicotine addition. N Engl J Med 1988;319:1318-1330.
22. Meshul CK, Kamel D, Moore C, Kay TS, Krentz L: Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats. Exp Neurol 2002;175:257-274.
23. Wilder J: Adrenalin and the law of initial value; a critical survey. Exp Med Surg 1957;15:47-67.
24. Padbury JF, Roberman B, Oddie TH, Hobel CJ, Fisher DA: Fetal catecholamine release in response to labor and delivery. Obstet. Gynecol 1982;60:607-611.
25. Oncken CA, Henry KM, Campbell WA, Kuhn CM, Slotkin TA, Kranzler HR: Effect of maternal smoking on fetal catecholamine concentrations at birth. Pediatr Res 2003;53:119-124.
26. Dajas-Bailador FA, Soliakov L, Wonnacott S: Nicotine activates the extracellular signal-regulated kinase 1/2 via the alpha7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurons. J Neurochem 2002;80:520-530.
27. Bridge MH, Williams E, Lyons MEG, Tipton KF, Linert W: Electrochemical investigation into the redox activity of Fe(II)/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases. Biochim Biophys Acta 2004;1690:77-84.
28. Belluardo N, Mudo G, Blum M, Fuxe K: Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav Brain Res 2000;113:21-34.